Jeil Pharma Holdings Inc

Research Jeil Pharma Holdings Inc (002620.KS) on Bullrun: market cap KRW 112.22B, dividend yield 1.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker002620.KS
• ExchangeKS
• CountrySouth Korea
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyKRW
• Market capKRW 112.22B
• Dividend yield1.0%
• Financial periodQ2 2026
• RevenueKRW 164.70B
• Net income-KRW 3.55B
• Free cash flow-KRW 11.66B
• Gross margin38.3%

Valuation Snapshot

latest market cap is KRW 112.22B; dividend yield is 1.0%.

Peer valuation comparison

Latest dividend yield is 0.96% versus a Healthcare sector median of 2.4% (60.0% below).

Valuation history

Dividend history

Latest trailing dividend snapshot: annual dividend/share 70 KRW, yield 1.0%.

About Jeil Pharma Holdings Inc

Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Jeil Pharma Holdings Inc's market cap?

Jeil Pharma Holdings Inc's market capitalization is KRW 112.22B.

Does Jeil Pharma Holdings Inc pay a dividend?

Jeil Pharma Holdings Inc has a dividend yield of 1.0%.

What does Jeil Pharma Holdings Inc do?

Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products.